Advanced
  Home Compare Reports

Comparison with Similar Reports

Hemodialysis and Peritoneal Dialysis Market by Product (Machine, Bloodline, Tube, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Service...

Publisher:        MarketsandMarkets

# of Pages:        322

Rating: 

1 User License $4,950

Publication Date:  August, 2021

Price:       $4,950 / User License




1 INTRODUCTION 49
1.1 OBJECTIVES OF THE STUDY 49
1.2 MARKET DEFINITION 49
1.2.1 INCLUSIONS & EXCLUSIONS 49
1.3 MARKET SCOPE 50
1.3.1 MARKETS COVERED 50
1.3.2 YEARS CONSIDERED FOR THE STUDY 51
1.4 CURRENCY USED FOR THE STUDY 51
1.5 MAJOR MARKET STAKEHOLDERS 51
1.6 SUMMARY OF CHANGES 52
2 RESEARCH METHODOLOGY 53
2.1 RESEARCH DATA 53
FIGURE 1 RESEARCH DESIGN 53
2.1.1 SECONDARY DATA 54
2.1.1.1 Secondary sources 55
2.1.2 PRIMARY DATA 56
FIGURE 2 BREAKDOWN OF PRIMARIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET 56
2.2 MARKET ESTIMATION METHODOLOGY 56
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 57
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 57
2.2.2 USAGE-BASED MARKET ESTIMATION 58
FIGURE 4 ESTIMATION OF HEMODIALYSIS AND PERITONEAL DIALYSIS PROCEDURES BY COUNTRY/REGION 58
FIGURE 5 MARKET SIZE ESTIMATION: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET BASED ON PRODUCT UTILIZATION METHODOLOGY 59
FIGURE 6 MARKET SIZE ESTIMATION: HEMODIALYSIS AND PERITONEAL DIALYSIS SERVICES MARKET BASED ON REVENUE MAPPING METHODOLOGY 59
2.2.3 PRIMARY RESEARCH VALIDATION 60
2.3 COVID-19 HEALTH ASSESSMENT 60
2.4 COVID-19 ECONOMIC ASSESSMENT 60
2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 61
FIGURE 7 CRITERIA IMPACTING THE GLOBAL ECONOMY 61
FIGURE 8 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 62
2.6 DATA TRIANGULATION 63
FIGURE 9 DATA TRIANGULATION METHODOLOGY 63
2.7 RESEARCH ASSUMPTIONS 64
2.8 RESEARCH LIMITATIONS 64
3 EXECUTIVE SUMMARY 65
FIGURE 10 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, BY TYPE,
2021 VS. 2026 (USD BILLION) 65
FIGURE 11 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD BILLION) 66
FIGURE 12 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD BILLION) 67
FIGURE 13 HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 67
FIGURE 14 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY USAGE,
2021 VS. 2026 (USD BILLION) 68
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET 69
4 PREMIUM INSIGHTS 70
4.1 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET OVERVIEW 70
FIGURE 16 RISING PREVALENCE OF ESRD AND GROWING AWARENESS ABOUT DIALYSIS TREATMENT TO DRIVE MARKET GROWTH 70
4.2 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, BY TYPE, 2021 70
FIGURE 17 HEMODIALYSIS TO DOMINATE THE MARKET IN 2021 70
4.3 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2021 VS 2026 (USD BILLION) 71
FIGURE 18 HEMODIALYSIS MACHINES TO REGISTER THE HIGHEST GROWTH IN THE HEMODIALYSIS MARKET DURING THE FORECAST PERIOD 71
4.4 HEMODIALYSIS MARKET, BY TYPE, 2021 VS 2026 (USD BILLION) 71
FIGURE 19 SHORT DAILY HEMODIALYSIS SEGMENT TO REGISTER THE HIGHEST CAGR IN THE MARKET DURING THE FORECAST PERIOD 71
FIGURE 20 APAC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2021–2026) 72
5 MARKET OVERVIEW 73
5.1 INTRODUCTION 73
5.2 MARKET DYNAMICS 73
FIGURE 21 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 73
5.2.1 DRIVERS 74
5.2.1.1 Increasing number of ESRD patients 74
FIGURE 22 US: PREVALENCE OF ESRD, BY AGE GROUP, 2010–2018 74
TABLE 1 NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION, 2019 VS. 2050 75
5.2.1.2 Growing prevalence of diabetes and hypertension 75
FIGURE 23 US: REPORTED CAUSES OF ESRD FOR ALL AGES, 2018 75
5.2.1.3 Shortage of organ donors and risks associated with kidney transplants 76
5.2.1.4 Technological advancements and product launches 76
5.2.2 RESTRAINTS 77
5.2.2.1 Risks and complications of dialysis 77
5.2.2.2 Reimbursement concerns in emerging markets 77
5.2.3 OPPORTUNITIES 77
5.2.3.1 Emerging markets 77
FIGURE 24 ASIA: INCIDENCE OF TREATED ESRD, BY AGE AND COUNTRY, 2018 78
5.2.3.2 The increasing number of dialysis centers 78
5.2.3.3 Growing preference for home hemodialysis treatment 79
5.2.4 CHALLENGES 80
5.2.4.1 Benefits of renal transplantation 80
5.2.4.1.1 Low cost 80
5.2.4.1.2 Better survival rate 80
5.2.4.2 Sustainability of small and medium-sized companies in a highly competitive market 81
5.2.4.3 Product recalls 81
5.3 REGULATORY LANDSCAPE 82
5.3.1 NORTH AMERICA 82
5.3.1.1 US 82
5.3.1.2 Canada 82
5.3.2 EUROPE 82
5.3.3 ASIA PACIFIC 83
5.3.3.1 India 83
5.3.3.2 China 83
5.3.3.3 Japan 83
5.3.3.4 South Korea 83
5.3.4 REST OF THE WORLD 84
5.3.4.1 Latin America 84
5.3.4.1.1 Brazil 84
5.3.4.1.2 Mexico 84
5.3.4.2 Middle East 85
5.3.4.3 Africa 85
5.4 GLOBAL REIMBURSEMENT SCENARIO 85
5.4.1 NORTH AMERICA 85
5.4.2 EUROPE 86
5.4.2.1 Germany 87
5.4.2.2 France 87
5.4.2.3 Belgium 87
5.4.2.4 UK 87
5.4.2.5 Netherlands 88
TABLE 2 REIMBURSEMENT PER WEEK FOR DIALYSIS SERVICES IN EUROPEAN COUNTRIES (USD) 88
5.4.3 ASIA PACIFIC 88
5.4.3.1 India 88
5.4.3.2 China 89
5.4.3.3 Japan 89
5.4.3.4 Other Asian Countries 89
5.4.3.5 Pacific Region 89
5.5 COVID-19 IMPACT ON THE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET 90
FIGURE 25 CONFIRMED COVID-19 CASES AMONG PATIENTS RECEIVING KIDNEY REPLACEMENT THERAPY, BY PARTICIPATING COUNTRY, JANUARY–AUGUST 2020 90
FIGURE 26 US: COVID-19 HOSPITALIZATION DATA FOR SPECIALIZED MEDICAL CONDITIONS IN ADULTS (AS OF APRIL 11, 2020) 91
5.6 CASE STUDY: GLOBAL DIALYSIS PROCEDURE DATA 91
TABLE 3 HEMODIALYSIS AND PERITONEAL DIALYSIS TREATMENT PROCEDURES FOR KEY COUNTRIES, AS OF 2020 92
5.7 VALUE CHAIN ANALYSIS 92
FIGURE 27 VALUE CHAIN OF THE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET 93
5.8 PRICING TREND ANALYSIS 93
TABLE 4 AVERAGE PRICE OF HEMODIALYSIS AND PERITONEAL DIALYSIS SYSTEMS AND CONSUMABLES, BY COUNTRY, 2020 (USD) 93
5.9 PORTER’S FIVE FORCES ANALYSIS 94
TABLE 5 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 94
5.9.1 THREAT FROM NEW ENTRANTS 94
FIGURE 28 THREAT FROM NEW ENTRANTS 94
5.9.2 THREAT FROM SUBSTITUTES 95
FIGURE 29 THREAT FROM SUBSTITUTES 95
5.9.3 BARGAINING POWER OF SUPPLIERS 95
FIGURE 30 BARGAINING POWER OF SUPPLIERS 95
5.9.4 BARGAINING POWER OF BUYERS 96
FIGURE 31 BARGAINING POWER OF BUYERS 96
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 96
FIGURE 32 INTENSITY OF COMPETITIVE RIVALRY 97
5.10 ECOSYSTEM COVERAGE 97
6 HEMODIALYSIS MARKET 98
6.1 INTRODUCTION 99
TABLE 6 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD BILLION) 99
6.2 HEMODIALYSIS SERVICES 99
TABLE 7 HEMODIALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD BILLION) 100
TABLE 8 HEMODIALYSIS SERVICES MARKET, BY REGION, 2019–2026 (USD BILLION) 100
6.2.1 IN-CENTER HEMODIALYSIS SERVICES 100
6.2.1.1 Growth in the patient base and support for treatment are driving the demand for in-center services 100
TABLE 9 IN-CENTER HEMODIALYSIS SERVICES MARKET, BY REGION,
2019–2026 (USD BILLION) 101
6.2.2 HOME HEMODIALYSIS SERVICES 101
6.2.2.1 Poor reimbursement scenario for HHD has hindered the market growth 101
TABLE 10 HOME HEMODIALYSIS SERVICES MARKET, BY REGION,
2019–2026 (USD BILLION) 101
6.3 HEMODIALYSIS PRODUCTS 102
TABLE 11 HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2019–2026 (USD BILLION) 102
TABLE 12 HEMODIALYSIS PRODUCTS MARKET, BY REGION, 2019–2026 (USD BILLION) 102
6.3.1 HEMODIALYSIS MACHINES 103
TABLE 13 HEMODIALYSIS MACHINES MARKET, BY TYPE, 2019–2026 (USD BILLION) 103
TABLE 14 HEMODIALYSIS MACHINES MARKET, BY REGION, 2019–2026 (USD BILLION) 103
6.3.1.1 Center-use hemodialysis machines 104
6.3.1.1.1 The rising number of renal care centers has ensured steady demand for center-use machines 104
TABLE 15 CENTER-USE HEMODIALYSIS MACHINES MARKET, BY REGION,
2019–2026 (USD BILLION) 104
6.3.1.2 Home-use hemodialysis machines 104
6.3.1.2.1 HHD machines have gained significance due to their improved clinical outcomes & better quality of life for patients 104
TABLE 16 HOME-USE HEMODIALYSIS MACHINES MARKET, BY REGION,
2019–2026 (USD BILLION) 105
6.3.2 HEMODIALYSIS CONSUMABLES & SUPPLIES 105
TABLE 17 HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE,
2019–2026 (USD BILLION) 106
TABLE 18 HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY REGION,
2019–2026 (USD BILLION) 106
6.3.2.1 Dialyzers 106
TABLE 19 DIALYZERS MARKET, BY REGION, 2019–2026 (USD BILLION) 107
6.3.2.1.1 Dialyzers market, by material 107
TABLE 20 DIALYZERS MARKET, BY MATERIAL, 2019–2026 (USD BILLION) 107
6.3.2.1.1.1 Synthetic dialyzers 108
6.3.2.1.1.2 Ease of sterilization, high strength, and resistance of synthetic dialyzers account for their wide use 108
TABLE 21 SYNTHETIC DIALYZERS MARKET, BY REGION, 2019–2026 (USD BILLION) 108
6.3.2.1.1.3 Cellulose-based dialyzers 109
6.3.2.1.1.4 High biocompatibility and affordability have enabled market growth 109
TABLE 22 CELLULOSE-BASED DIALYZERS MARKET, BY REGION,
2019–2026 (USD BILLION) 109
6.3.2.1.2 Dialyzers market, by flux 109
TABLE 23 DIALYZERS MARKET, BY FLUX, 2019–2026 (USD BILLION) 109
6.3.2.1.2.1 High-flux dialyzers 110
6.3.2.1.2.2 High-flux dialyzers can clear medium-sized molecules and prevent the removal of proteins from the blood 110
TABLE 24 HIGH-FLUX DIALYZERS MARKET, BY REGION, 2019–2026 (USD BILLION) 110
6.3.2.1.3 Low-flux dialyzers 110
6.3.2.1.3.1 The capability to remove smaller-sized molecules have made low-flux dialyzers popular 110
TABLE 25 LOW-FLUX DIALYZERS MARKET, BY REGION, 2019–2026 (USD BILLION) 111
6.3.2.2 Bloodlines 111
6.3.2.2.1 Bloodline reuse in emerging markets is a key challenge to the growth of this segment 111
TABLE 26 BLOODLINES MARKET, BY REGION, 2019–2026 (USD BILLION) 111
6.3.2.3 HD concentrates/dialysates 112
TABLE 27 HD CONCENTRATES/DIALYSATES MARKET, BY TYPE,
2019–2026 (USD BILLION) 112
TABLE 28 HD CONCENTRATES/DIALYSATES MARKET, BY REGION,
2019–2026 (USD BILLION) 112
6.3.2.3.1 Alkaline concentrates 113
6.3.2.3.1.1 Growing consumption of alkaline concentrates for dialysis procedures to boost the market growth 113
TABLE 29 ALKALINE CONCENTRATES MARKET, BY REGION, 2019–2026 (USD BILLION) 113
6.3.2.3.2 Acidic concentrates 113
6.3.2.3.2.1 Side-effects associated with acidic concentrate to hinder the growth 113
TABLE 30 ACIDIC CONCENTRATES MARKET, BY REGION, 2019–2026 (USD BILLION) 114
6.3.2.4 Access products 114
TABLE 31 ACCESS PRODUCTS MARKET, BY TYPE, 2019–2026 (USD BILLION) 114
TABLE 32 ACCESS PRODUCTS MARKET, BY REGION, 2019–2026 (USD BILLION) 115
6.3.2.4.1 AV fistula needles 115
6.3.2.4.1.1 AV fistula access provides better blood flow and a lower risk of infections 115
TABLE 33 AV FISTULA NEEDLES MARKET, BY REGION, 2019–2026 (USD BILLION) 115
6.3.2.4.2 AV grafts 116
6.3.2.4.2.1 Synthetic AV grafts are more widely used than their biological counterparts 116
TABLE 34 AV GRAFTS MARKET, BY REGION, 2019–2026 (USD BILLION) 116
6.3.2.4.3 Central venous catheters 116
6.3.2.4.3.1 Catheters can be used in the long term if grafts and fistula are unsuccessful 116
TABLE 35 CENTRAL VENOUS CATHETERS MARKET, BY REGION,
2019–2026 (USD BILLION) 117
6.3.2.5 Other hemodialysis consumables & supplies 117
TABLE 36 OTHER HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY REGION, 2019–2026 (USD BILLION) 117
6.4 HEMODIALYSIS MARKET, BY TYPE 118
TABLE 37 HEMODIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 118
6.4.1 CONVENTIONAL LONG-TERM HEMODIALYSIS 118
6.4.1.1 Technological advancements and rising number of dialysis centers are likely to drive the segment growth 118
TABLE 38 CONVENTIONAL LONG-TERM HEMODIALYSIS MARKET, BY REGION,
2019–2026 (USD BILLION) 119
6.4.2 SHORT DAILY HEMODIALYSIS 119
6.4.2.1 Daily HD has demonstrated better outcomes than conventional HD 119
TABLE 39 SHORT DAILY HEMODIALYSIS MARKET, BY REGION,
2019–2026 (USD BILLION) 120
6.4.3 NOCTURNAL HEMODIALYSIS 120
6.4.3.1 Rising awareness to boost the demand for NHD in the coming years 120
TABLE 40 NOCTURNAL HEMODIALYSIS MARKET, BY REGION,
2019–2026 (USD BILLION) 121
6.5 WATER TREATMENT SYSTEMS MARKET, BY TYPE 121
TABLE 41 WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 42 WATER TREATMENT SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 122
6.5.1 CENTRAL WATER DISINFECTION SYSTEMS 122
TABLE 43 CENTRAL WATER DISINFECTION SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 122
TABLE 44 CENTRAL WATER DISINFECTION SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 123
6.5.1.1 Central heat disinfection systems 123
6.5.1.1.1 Heat disinfection systems lower the labor costs and disposable issues associated with chemicals 123
TABLE 45 CENTRAL HEAT DISINFECTION SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 124
6.5.1.2 Central chemical disinfection systems 124
6.5.1.2.1 Cost-effectiveness has ensured end-user preference for chemical disinfection 124
TABLE 46 CENTRAL CHEMICAL DISINFECTION SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 125
6.5.1.3 Central water disinfection system accessories 125
TABLE 47 CENTRAL WATER DISINFECTION SYSTEM ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION) 125
6.5.2 PORTABLE WATER DISINFECTION SYSTEMS 126
TABLE 48 PORTABLE WATER DISINFECTION SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 126
TABLE 49 PORTABLE WATER DISINFECTION SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 127
6.5.2.1 Portable heat disinfection systems 127
6.5.2.1.1 Launch of advanced systems to drive the market growth 127
TABLE 50 PORTABLE HEAT DISINFECTION SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 127
6.5.2.2 Portable chemical disinfection systems 128
6.5.2.2.1 Chemical disinfection systems to dominate the central water disinfection system market during the forecast period 128
TABLE 51 PORTABLE CHEMICAL DISINFECTION SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 128
6.5.2.3 Portable water disinfection system accessories 128
6.5.2.3.1 Stringent regulations pose a hurdle to accessory approvals 128
TABLE 52 PORTABLE WATER DISINFECTION SYSTEM ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION) 129
7 PERITONEAL DIALYSIS MARKET 130
7.1 INTRODUCTION 131
TABLE 53 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD BILLION) 131
7.2 PERITONEAL DIALYSIS PRODUCTS 131
TABLE 54 PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 132
TABLE 55 PERITONEAL DIALYSIS PRODUCTS MARKET, BY REGION,
2019–2026 (USD BILLION) 132
7.2.1 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES 132
7.2.1.1 High demand for PD concentrates has prompted players to focus on improving their manufacturing capabilities 132
TABLE 56 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET, BY REGION, 2019–2026 (USD BILLION) 133
7.2.2 PERITONEAL DIALYSIS MACHINES 133
7.2.2.1 Rising prevalence of chronic diseases in emerging countries to boost the adoption of home peritoneal dialysis 133
TABLE 57 PERITONEAL DIALYSIS MACHINES MARKET, BY REGION,
2019–2026 (USD BILLION) 134
7.2.3 PERITONEAL DIALYSIS CATHETERS 134
7.2.3.1 Favorable changes in the reimbursement policies for PD catheters to support market growth 134
TABLE 58 PERITONEAL DIALYSIS CATHETERS MARKET, BY REGION,
2019–2026 (USD BILLION) 135
7.2.4 PERITONEAL DIALYSIS TRANSFER SETS 135
7.2.4.1 Shift towards home dialysis is likely to increase the adoption of PD transfer sets 135
TABLE 59 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY REGION,
2019–2026 (USD BILLION) 135
7.2.5 OTHER PERITONEAL DIALYSIS PRODUCTS 136
TABLE 60 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY REGION,
2019–2026 (USD BILLION) 136
7.3 PERITONEAL DIALYSIS SERVICES 136
7.3.1 PRIVACY AND COMFORT OF DIALYSIS TREATMENT AT HOME IS DRIVING THE DEMAND FOR PD SERVICES 136
TABLE 61 PERITONEAL DIALYSIS SERVICES MARKET, BY REGION,
2019–2026 (USD BILLION) 137
7.4 PERITONEAL DIALYSIS MARKET, BY MODALITY 137
TABLE 62 PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2026 (USD BILLION) 137
7.4.1 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS 138
7.4.1.1 CAPD offers a wide range of advantages over APD 138
TABLE 63 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS MARKET, BY REGION, 2019–2026 (USD BILLION) 138
7.4.2 AMBULATORY PERITONEAL DIALYSIS 138
7.4.2.1 Risk of rapid decline in residual renal functions with APD to limit its adoption 138
TABLE 64 AMBULATORY PERITONEAL DIALYSIS MARKET, BY REGION,
2019–2026 (USD BILLION) 139
8 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY USAGE 140
8.1 INTRODUCTION 141
TABLE 65 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY USAGE,
2019–2026 (USD BILLION) 141
8.2 IN-CENTER DIALYSIS 141
TABLE 66 IN-CENTER DIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 142
8.2.1 INDEPENDENT DIALYSIS 142
8.2.1.1 Independent dialysis is the largest & fastest-growing segment of the in-center dialysis market 142
TABLE 67 INDEPENDENT DIALYSIS MARKET, BY REGION, 2019–2026 (USD BILLION) 142
8.2.2 HOSPITAL DIALYSIS 143
8.2.2.1 Increasing government support to develop dialysis treatment facilities in hospitals to drive market growth 143
TABLE 68 HOSPITAL DIALYSIS MARKET, BY REGION, 2019–2026 (USD BILLION) 143
8.2.3 HOME DIALYSIS 143
TABLE 69 HOME DIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 144
8.2.4 PERITONEAL DIALYSIS 144
8.2.4.1 Peritoneal dialysis costs significantly less than hemodialysis 144
TABLE 70 PERITONEAL DIALYSIS MARKET, BY REGION, 2019–2026 (USD BILLION) 145
8.2.5 HOME HEMODIALYSIS 145
8.2.5.1 Favorable reimbursement scenario in developed countries and the growing awareness about home dialysis to drive market growth 145
TABLE 71 HOME HEMODIALYSIS MARKET, BY REGION, 2019–2026 (USD BILLION) 145
9 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION 146
9.1 INTRODUCTION 147
TABLE 72 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION, 2019–2026 (USD BILLION) 147
9.2 END-STAGE RENAL DISEASE 147
9.2.1 ASIA HAS THE HIGHEST PREVALENCE OF ESRD 147
TABLE 73 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR ESRD, BY REGION, 2019–2026 (USD BILLION) 148
9.3 ACUTE KIDNEY INJURY 148
9.3.1 PATIENTS WITH AKI REQUIRING DIALYSIS ARE COMMONLY TREATED WITH HEMODIALYSIS OR HEMOFILTRATION 148
TABLE 74 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR ACUTE KIDNEY INJURY, BY REGION, 2019–2026 (USD BILLION) 149
9.4 SEPTIC SHOCK 149
9.4.1 GROWING PREVALENCE OF SEPSIS IN EMERGING COUNTRIES TO INCREASE THE NEED FOR HEMODIALYSIS TREATMENT 149
TABLE 75 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR SEPTIC SHOCK, BY REGION, 2019–2026 (USD BILLION) 150
9.5 MULTIPLE ORGAN FAILURE 150
9.5.1 BENEFITS OF CRRT OVER HD TO REDUCE THE UPTAKE OF HD IN PATIENTS DEVELOPING MULTIPLE ORGAN FAILURE 150
TABLE 76 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR MULTIPLE ORGAN FAILURE, BY REGION, 2019–2026 (USD BILLION) 150
9.6 OTHER DISEASE INDICATIONS 151
TABLE 77 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR OTHER DISEASE INDICATIONS, BY REGION, 2019–2026 (USD BILLION) 151
10 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION 152
10.1 INTRODUCTION 153
TABLE 78 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION,
2019–2026 (USD BILLION) 153
10.2 NORTH AMERICA 153
TABLE 79 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019–2026 (USD BILLION) 154
TABLE 80 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 154
TABLE 81 NORTH AMERICA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 154
TABLE 82 NORTH AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE,
2019–2026 (USD BILLION) 155
TABLE 83 NORTH AMERICA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2019–2026 (USD BILLION) 155
TABLE 84 NORTH AMERICA: HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL,
2019–2026 (USD BILLION) 155
TABLE 85 NORTH AMERICA: HEMODIALYSIS DIALYZERS MARKET, BY FLUX,
2019–2026 (USD BILLION) 156
TABLE 86 NORTH AMERICA: HEMODIALYSIS CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2019–2026 (USD BILLION) 156
TABLE 87 NORTH AMERICA: HEMODIALYSIS ACCESS PRODUCTS MARKET, BY TYPE, 2019–2026 (USD BILLION) 156
TABLE 88 NORTH AMERICA: HEMODIALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD BILLION) 157
TABLE 89 NORTH AMERICA: HEMODIALYSIS MARKET, BY TYPE,
2019–2026 (USD BILLION) 157
TABLE 90 NORTH AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 91 NORTH AMERICA: CENTRAL WATER TREATMENT SYSTEM MARKET, BY TYPE, 2019–2026 (USD MILLION) 158
TABLE 92 NORTH AMERICA: PORTABLE WATER TREATMENT SYSTEM MARKET, BY TYPE, 2019–2026 (USD MILLION) 158
TABLE 93 NORTH AMERICA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2019–2026 (USD BILLION) 158
TABLE 94 NORTH AMERICA: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2019–2026 (USD BILLION) 159
10.2.1 US 159
10.2.1.1 Bundled reimbursement is a strong incentive for dialysis providers to encourage the adoption of home PD 159
TABLE 95 US: HEMODIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 160
TABLE 96 US: HEMODIALYSIS MACHINES MARKET, BY TYPE,
2019–2026 (USD BILLION) 160
TABLE 97 US: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE,
2019–2026 (USD BILLION) 160
TABLE 98 US: HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL,
2019–2026 (USD BILLION) 161
TABLE 99 US: HEMODIALYSIS DIALYZERS MARKET, BY FLUX,
2019–2026 (USD BILLION) 161
TABLE 100 US: HEMODIALYSIS CONCENTRATES/DIALYSATES MARKET, BY TYPE,
2019–2026 (USD BILLION) 161
TABLE 101 US: HEMODIALYSIS ACCESS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 162
TABLE 102 US: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD BILLION) 162
TABLE 103 US: HEMODIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 162
TABLE 104 US: WATER TREATMENT SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 105 US: CENTRAL WATER TREATMENT SYSTEM MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 106 US: PORTABLE WATER TREATMENT SYSTEM MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 107 US: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 164
TABLE 108 US: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2019–2026 (USD BILLION) 164
10.2.2 CANADA 164
10.2.2.1 Shortage of dialysis facilities is restraining the growth of the market in Canada 164
TABLE 109 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 165
TABLE 110 CANADA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 165
TABLE 111 CANADA: HEMODIALYSIS MACHINES MARKET, BY TYPE,
2019–2026 (USD BILLION) 165
TABLE 112 CANADA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2019–2026 (USD BILLION) 166
TABLE 113 CANADA: HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL,
2019–2026 (USD BILLION) 166
TABLE 114 CANADA: HEMODIALYSIS DIALYZERS MARKET, BY FLUX,
2019–2026 (USD BILLION) 166
TABLE 115 CANADA: HEMODIALYSIS CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2019–2026 (USD BILLION) 167
TABLE 116 CANADA: HEMODIALYSIS ACCESS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 167
TABLE 117 CANADA: HEMODIALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD BILLION) 167
TABLE 118 CANADA: HEMODIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 168
TABLE 119 CANADA: WATER TREATMENT SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 168
TABLE 120 CANADA: CENTRAL WATER TREATMENT SYSTEM MARKET, BY TYPE,
2019–2026 (USD MILLION) 168
TABLE 121 CANADA: PORTABLE WATER TREATMENT SYSTEM MARKET, BY TYPE,
2019–2026 (USD MILLION) 169
TABLE 122 CANADA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 169
TABLE 123 CANADA: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2019–2026 (USD BILLION) 169
10.3 EUROPE 170
TABLE 124 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019–2026 (USD BILLION) 170
TABLE 125 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 171
TABLE 126 EUROPE: HEMODIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 171
TABLE 127 EUROPE: HEMODIALYSIS MACHINES MARKET, BY TYPE,
2019–2026 (USD BILLION) 171
TABLE 128 EUROPE: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2019–2026 (USD BILLION) 172
TABLE 129 EUROPE: HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL,
2019–2026 (USD BILLION) 172
TABLE 130 EUROPE: HEMODIALYSIS DIALYZERS MARKET, BY FLUX,
2019–2026 (USD BILLION) 172
TABLE 131 EUROPE: HEMODIALYSIS CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2019–2026 (USD BILLION) 173
TABLE 132 EUROPE: HEMODIALYSIS ACCESS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 173
TABLE 133 EUROPE: HEMODIALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD BILLION) 173
TABLE 134 EUROPE: HEMODIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 174
TABLE 135 EUROPE: WATER TREATMENT SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 174
TABLE 136 EUROPE: CENTRAL WATER TREATMENT SYSTEM MARKET, BY TYPE,
2019–2026 (USD MILLION) 174
TABLE 137 EUROPE: PORTABLE WATER TREATMENT SYSTEM MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 138 EUROPE: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 175
TABLE 139 EUROPE: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2019–2026 (USD BILLION) 175
10.3.1 GERMANY 176
10.3.1.1 Germany offers better reimbursement for PD than HD 176
TABLE 140 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 176
TABLE 141 GERMANY: HEMODIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 176
TABLE 142 GERMANY: HEMODIALYSIS MACHINES MARKET, BY TYPE,
2019–2026 (USD BILLION) 177
TABLE 143 GERMANY: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2019–2026 (USD BILLION) 177
TABLE 144 GERMANY: HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL,
2019–2026 (USD BILLION) 177
TABLE 145 GERMANY: HEMODIALYSIS DIALYZERS MARKET, BY FLUX,
2019–2026 (USD BILLION) 178
TABLE 146 GERMANY: HEMODIALYSIS CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2019–2026 (USD BILLION) 178
TABLE 147 GERMANY: HEMODIALYSIS ACCESS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 178
TABLE 148 GERMANY: HEMODIALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD BILLION) 179
TABLE 149 GERMANY: HEMODIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 179
TABLE 150 GERMANY: WATER TREATMENT SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 179
TABLE 151 GERMANY: CENTRAL WATER TREATMENT SYSTEM MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 152 GERMANY: PORTABLE WATER TREATMENT SYSTEM MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 153 GERMANY: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 180
TABLE 154 GERMANY: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2019–2026 (USD BILLION) 181
10.3.2 UK 181
10.3.2.1 Rising number of new dialysis centers to support market growth 181
TABLE 155 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE,
2019–2026 (USD BILLION) 182
TABLE 156 UK: HEMODIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 182
TABLE 157 UK: HEMODIALYSIS MACHINES MARKET, BY TYPE,
2019–2026 (USD BILLION) 182
TABLE 158 UK: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE,
2019–2026 (USD BILLION) 183
TABLE 159 UK: HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL,
2019–2026 (USD BILLION) 183
TABLE 160 UK: HEMODIALYSIS DIALYZERS MARKET, BY FLUX,
2019–2026 (USD BILLION) 183
TABLE 161 UK: HEMODIALYSIS CONCENTRATES/DIALYSATES MARKET, BY TYPE,
2019–2026 (USD BILLION) 184
TABLE 162 UK: HEMODIALYSIS ACCESS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 184
TABLE 163 UK: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD BILLION) 184
TABLE 164 UK: HEMODIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 185
TABLE 165 UK: WATER TREATMENT SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 166 UK: CENTRAL WATER TREATMENT SYSTEM MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 167 UK: PORTABLE WATER TREATMENT SYSTEM MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 168 UK: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 186
TABLE 169 UK: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2019–2026 (USD BILLION) 186
10.3.3 FRANCE 187
10.3.3.1 High cost of dialysis treatment and variation in reimbursement policies are likely to restrain the market growth 187
TABLE 170 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 187
TABLE 171 FRANCE: HEMODIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 187
TABLE 172 FRANCE: HEMODIALYSIS MACHINES MARKET, BY TYPE,
2019–2026 (USD BILLION) 188
TABLE 173 FRANCE: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2019–2026 (USD BILLION) 188
TABLE 174 FRANCE: HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL,
2019–2026 (USD BILLION) 188
TABLE 175 FRANCE: HEMODIALYSIS DIALYZERS MARKET, BY FLUX,
2019–2026 (USD BILLION) 189
TABLE 176 FRANCE: HEMODIALYSIS CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2019–2026 (USD BILLION) 189
TABLE 177 FRANCE: HEMODIALYSIS ACCESS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 189
TABLE 178 FRANCE: HEMODIALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD BILLION) 190
TABLE 179 FRANCE: HEMODIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 190
TABLE 180 FRANCE: WATER TREATMENT SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 190
TABLE 181 FRANCE: CENTRAL WATER TREATMENT SYSTEM MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 182 FRANCE: PORTABLE WATER TREATMENT SYSTEM MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 183 FRANCE: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 191
TABLE 184 FRANCE: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2019–2026 (USD BILLION) 192
10.3.4 ITALY 192
10.3.4.1 Increasing research activities to promote the awareness of hemodialysis and peritoneal dialysis to drive market growth 192
TABLE 185 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE,
2019–2026 (USD BILLION) 192
TABLE 186 ITALY: HEMODIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 193
TABLE 187 ITALY: HEMODIALYSIS MACHINES MARKET, BY TYPE,
2019–2026 (USD BILLION) 193
TABLE 188 ITALY: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2019–2026 (USD BILLION) 193
TABLE 189 ITALY: HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL,
2019–2026 (USD BILLION) 194
TABLE 190 ITALY: HEMODIALYSIS DIALYZERS MARKET, BY FLUX,
2019–2026 (USD BILLION) 194
TABLE 191 ITALY: HEMODIALYSIS CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2019–2026 (USD BILLION) 194
TABLE 192 ITALY: HEMODIALYSIS ACCESS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 195
TABLE 193 ITALY: HEMODIALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD BILLION) 195
TABLE 194 ITALY: HEMODIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 195
TABLE 195 ITALY: WATER TREATMENT SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 196
TABLE 196 ITALY: CENTRAL WATER TREATMENT SYSTEM MARKET, BY TYPE,
2019–2026 (USD MILLION) 196
TABLE 197 ITALY: PORTABLE WATER TREATMENT SYSTEM MARKET, BY TYPE,
2019–2026 (USD MILLION) 196
TABLE 198 ITALY: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 197
TABLE 199 ITALY: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2019–2026 (USD BILLION) 197
10.3.5 SPAIN 197
10.3.5.1 Favorable reimbursement scenario to favor market growth 197
TABLE 200 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 198
TABLE 201 SPAIN: HEMODIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 198
TABLE 202 SPAIN: HEMODIALYSIS MACHINES MARKET, BY TYPE,
2019–2026 (USD BILLION) 198
TABLE 203 SPAIN: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2019–2026 (USD BILLION) 199
TABLE 204 SPAIN: HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL,
2019–2026 (USD BILLION) 199
TABLE 205 SPAIN: HEMODIALYSIS DIALYZERS MARKET, BY FLUX,
2019–2026 (USD BILLION) 199
TABLE 206 SPAIN: HEMODIALYSIS CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2019–2026 (USD BILLION) 200
TABLE 207 SPAIN: HEMODIALYSIS ACCESS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 200
TABLE 208 SPAIN: HEMODIALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD BILLION) 200
TABLE 209 SPAIN: HEMODIALYSIS MARKET, BY TYPE, 2019–2026 (USD BILLION) 201
TABLE 210 SPAIN: WATER TREATMENT SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 201
TABLE 211 SPAIN: CENTRAL WATER TREATMENT SYSTEM MARKET, BY TYPE,
2019–2026 (USD MILLION) 201
TABLE 212 SPAIN: PORTABLE WATER TREATMENT SYSTEM MARKET, BY TYPE,
2019–2026 (USD MILLION) 202
TABLE 213 SPAIN: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE,
2019–2026 (USD BILLION) 202
TABLE 214 SPAIN: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2019–2026 (USD BILLION) 202

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127